Status:

COMPLETED

Peer-Administered Asthma Self-Management Intervention in Urban Middle Schools

Lead Sponsor:

Rhode Island Hospital

Collaborating Sponsors:

University of Puerto Rico

Conditions:

Asthma

Eligibility:

All Genders

11-14 years

Phase:

NA

Brief Summary

Health disparities in pediatric asthma persist, with Latino children demonstrating increased asthma morbidity. Middle school children with asthma have greater morbidity than children from any other ag...

Detailed Description

The goal of this study is to evaluate a 4-session, peer-facilitated asthma self-management intervention for Latino, middle school (6th-8th) youth in urban public school settings. The intervention, ASM...

Eligibility Criteria

Inclusion

  • Inclusion Criteria specify that students must:
  • Be 11-14 years old
  • Attend 6th, 7th or 8th grade
  • attend a targeted public school
  • have physician-diagnosed asthma according to caregiver and provider report
  • meet criteria for current persistent asthma either by a) having a current prescription for an asthma controller medicine, or b) having any of the following in the previous 4 weeks:
  • I. daytime asthma symptoms \> 2 days/week,
  • II. nighttime awakenings due to asthma at least 3-4 times/month,
  • III. short-acting beta agonist use at least 2 days/week,
  • IV. activity limitation, or
  • V. oral steroid use at least 2 times/year
  • children must have recent active asthma activity in the previous 4 weeks through endorsement of any of criteria I-V above
  • In Rhode Island, children's primary caregiver must identify as Latino
  • In Rhode Island, children must speak English
  • Exclusion criteria:
  • active immunotherapy,
  • other pulmonary disease,
  • receiving special education services in a self-contained classroom,
  • any severe psychiatric or medical conditions

Exclusion

    Key Trial Info

    Start Date :

    April 1 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 31 2024

    Estimated Enrollment :

    243 Patients enrolled

    Trial Details

    Trial ID

    NCT03446365

    Start Date

    April 1 2019

    End Date

    May 31 2024

    Last Update

    September 27 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Rhode Island Hospital

    Providence, Rhode Island, United States, 02903